Loma Linda University

Enrollment Information
Call us at: 909-558-1000

Faculty Directory
  
Naomi Florea, PharmD
Chair, Experiential and Continuing Education
School of Pharmacy
Associate Professor, Pharmacy Practice
School of Pharmacy
Publications    Scholarly Journals--Published
  • Florea NR, Kuti JL, Nightingale CH, Nicolau DP. "Prevalence and Characteristics of Intravenous to Oral Conversion Programs for Anti-Infectives in the Unites States." Hospital Pharmacy 39.11 (2004): 1069-1075. ( 1/2004 )
  • Florea NR, Kuti JL, Nightingale CH, Dicolau DP. "Prevalence and Characteristics of Intravenous to Oral Conversion Programs in the United States." Hospital Pharmacy 39.11 (2004): 1069-1075. ( 1/2004 )
    Purpose: Despite the documented success of anti-infective intravenous to oral conversion programs, it is still unclear what the current standard of practice is in the United States. A survey was conducted to evaluate the prevalence and characteristics of conversion programs throughout the U.S. Methods: A questionnaire was mailed to 890 randomly chosen hospital pharmacy directors. A preset cutoff date of 4 weeks from the initial mailing was utilized for responses and a second mailing was sent to those directors that did not respond initially. Results: A total of 237 (27%) institutions responded. Of these, 74% had conversion programs instituted. More programs required prior physician notification compared with allowing pharmacists to proactively transition candidates (70% versus 30%, p
  • Florea NR, Kuti JL, Nightingale CH, Nicolau DP. "Prevalence and Characteristics of Intravenous to Oral Conversion Programs for Anti-Infectives in the United States." Hospital Pharmacy 39.11 (2004): 1069-1075. ( 1/2004 )
    Purpose: Despite the documented success of anti-infective intravenous to oral conversion programs, it is still unclear what the current standard of practice is in the United States. A survey was conducted to evaluate the prevalence and characteristics of conversion programs throughout the U.S. Methods: A questionnaire was mailed to 890 randomly chosen hospital pharmacy directors. A preset cutoff date of 4 weeks from the initial mailing was utilized for responses and a second mailing was sent to those directors that did not respond initially. Results: A total of 237 (27%) institutions responded. Of these, 74% had conversion programs instituted. More programs required prior physician notification compared with allowing pharmacists to proactively transition candidates (70% versus 30%, p
  • Arab S, Florea NR. "? Management Of Community Acquired Pneumonia In An Era Of Emerging Resistance: Implications for the Fluoroquinolones ." Pharmacotherapy . (): -. (*)
  • Arab S, Florea NR. "? Community Acquired Methicillin Resistant Staphylococcus Aureus ." CPHA Special Edition on Community Acquired Infections . (): -. (*)
  • Arab S, Florea NR. "Community Acquired Pneumonia ." CPHA Special Edition on Community Acquired Infections . (): -. (*)
  • Arab S, Florea NR. "? Community Acquired Clostridium difficile Associated ." CPHA Special Edition on Community Acquired Infections . (): -. (*)
  • Arab S, Florea NR. "? Pharmacist Implemented Program of an Human Immunodeficiency Virus (HIV) Patient Compliance Clinic ." Pharmacotherapy . (): -. (*)
  • Florea NR, Park JA. "Antimicrobial Efficacy Across Common Pathogens." Infectious Disease Special Edition . (): -. (*)